MX389490B - Peptidos y su uso en el tratamiento de la piel. - Google Patents

Peptidos y su uso en el tratamiento de la piel.

Info

Publication number
MX389490B
MX389490B MX2017008454A MX2017008454A MX389490B MX 389490 B MX389490 B MX 389490B MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 389490 B MX389490 B MX 389490B
Authority
MX
Mexico
Prior art keywords
peptides
skin treatment
compositions
skin
growth
Prior art date
Application number
MX2017008454A
Other languages
English (en)
Other versions
MX2017008454A (es
Inventor
Jolanta Idkowiak BALDYS
Uma Santhanam
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MX2017008454A publication Critical patent/MX2017008454A/es
Publication of MX389490B publication Critical patent/MX389490B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a los métodos de disminuir los signos de envejecimiento en y/o mejorar la salud de integumentos humanos tales como la piel, y a composiciones que comprenden péptidos útiles para ello. Las composiciones de acuerdo con la invención pueden comprender uno o más péptidos o fragmentos o derivados de los mismos derivados de un factor de crecimiento, p. ej., Factor de Diferenciación de Crecimiento 11 (GDF11) en un vehículo tópicamente aceptable.
MX2017008454A 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel. MX389490B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462095873P 2014-12-23 2014-12-23
PCT/US2015/048240 WO2016105607A1 (en) 2014-12-23 2015-09-03 Peptides and their use in the treatment of skin

Publications (2)

Publication Number Publication Date
MX2017008454A MX2017008454A (es) 2017-10-31
MX389490B true MX389490B (es) 2025-03-20

Family

ID=56128191

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008454A MX389490B (es) 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel.

Country Status (10)

Country Link
US (1) US10034826B2 (es)
EP (1) EP3236992B1 (es)
CN (1) CN107106652A (es)
BR (1) BR112017013696B1 (es)
CA (1) CA2972015A1 (es)
MX (1) MX389490B (es)
PH (1) PH12017501070B1 (es)
RU (1) RU2709778C2 (es)
WO (1) WO2016105607A1 (es)
ZA (1) ZA201704726B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101810385B1 (ko) * 2016-02-04 2017-12-20 주식회사 강스템바이오텍 Gdf11을 포함하는 조성물 및 그의 용도
US11766467B2 (en) 2017-09-01 2023-09-26 University Of Wyoming Methods of treating wounds using cathepsin K inhibitors
US10758559B1 (en) 2017-09-01 2020-09-01 University Of Wyoming Targeting cathepsin K to facilitate wound healing
JP2020533375A (ja) 2017-09-15 2020-11-19 カイン サイエンス シーオー., エルティーディー.KINE SCIENCES Co., Ltd. 自己免疫疾患および骨疾患の治療剤としてのペプチドの用途
CN108586575B (zh) * 2018-04-11 2020-08-14 福建省中科生物股份有限公司 一种多肽及其皮肤修复功能的应用
BR112021013164B1 (pt) 2019-01-04 2023-10-17 Avon Products, Inc Composição tópica compreendendo derivados oxidados de fragmentos de gdf-11 e método não terapêutico para diminuir o aparecimento de sinais dermatológicos de envelhecimento
CN114007589A (zh) * 2019-04-24 2022-02-01 富力卡姆股份公司 局部制剂
US20230320967A1 (en) * 2020-09-11 2023-10-12 Chemyunion Ltda. Composition, use of the composition, cosmetic method for modulating the production of sebum
KR20240133853A (ko) * 2023-02-28 2024-09-05 루다큐어 주식회사 신규 펩타이드 및 이의 용도

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US20030167492A1 (en) 1994-07-08 2003-09-04 Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
WO2001046220A2 (en) * 1999-12-22 2001-06-28 Polymun Scientific Immunbiologische Forschung Gmbh Bioactive oligopeptides
KR20050033512A (ko) 2001-10-05 2005-04-12 프로사이트 코포레이션 펩타이드 구리 착물 및 레티놀, 레티놀 유도체 또는이들의 혼합물을 함유하는 피부 보호 조성물
WO2004011650A2 (en) 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
ATE505199T1 (de) * 2002-11-08 2011-04-15 Soc Extraction Principes Actif Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides
ES2611984T3 (es) * 2004-06-14 2017-05-11 Basf Beauty Care Solutions France S.A.S. Preparaciones cosméticas que contienen fragmentos de PTH
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
HRP20120698T1 (hr) * 2007-01-25 2013-09-30 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Uporaba dgf-5 za poboljšanje ili održavanje izgleda kože
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
JP5647972B2 (ja) * 2008-04-08 2015-01-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 環状ペプチドを含む組成物および使用方法
EP2454368A4 (en) * 2009-07-17 2013-01-09 Aaron Thomas Tabor COMPOSITIONS AND METHOD FOR THE GENETIC MODIFICATION OF COSMETIC FUNCTION CELLS FOR IMPROVING THE COSMETIC APPEARANCE PICTURE
WO2011063128A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Implantable bone graft materials
JP2013515771A (ja) * 2009-12-28 2013-05-09 エヌ・ブイ・ペリコーン・リミテッド・ライアビリティ・カンパニー 局所用アシルグルタチオン製剤
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂
KR20130052441A (ko) * 2011-11-11 2013-05-22 (주) 코웰메디 재조합 인간 골형성 단백질과 트위스트 전사인자를 활성성분으로 함유하는 피부조직 재생용 조성물 및 키트
HK1206601A1 (en) 2012-04-02 2016-01-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
FR2998570B1 (fr) * 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
WO2014140890A2 (en) * 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
WO2014160496A1 (en) * 2013-03-13 2014-10-02 Stemetrix, Inc. Skin compositions and uses
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico
JP2016518357A (ja) * 2013-04-08 2016-06-23 プレジデント アンド フェローズ オブ ハーバード カレッジ 骨格筋幹細胞を若返らせる方法および組成物
US9125843B2 (en) * 2013-10-03 2015-09-08 Elc Management Llc Methods and compositions for improving the appearance of skin
WO2016105375A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170281507A1 (en) * 2014-12-23 2017-10-05 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
US20170281508A1 (en) * 2014-12-23 2017-10-05 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
US9597274B2 (en) * 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin

Also Published As

Publication number Publication date
RU2709778C2 (ru) 2019-12-20
EP3236992A1 (en) 2017-11-01
RU2017123388A (ru) 2019-01-24
EP3236992B1 (en) 2025-10-29
PH12017501070A1 (en) 2017-12-11
WO2016105607A1 (en) 2016-06-30
US10034826B2 (en) 2018-07-31
RU2017123388A3 (es) 2019-01-25
CN107106652A (zh) 2017-08-29
EP3236992A4 (en) 2018-09-05
BR112017013696B1 (pt) 2024-01-02
BR112017013696A2 (pt) 2018-02-06
ZA201704726B (en) 2019-01-30
PH12017501070B1 (en) 2022-04-29
MX2017008454A (es) 2017-10-31
US20160175225A1 (en) 2016-06-23
CA2972015A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
MX389490B (es) Peptidos y su uso en el tratamiento de la piel.
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
MX2019011764A (es) Composiciones limpiadoras y usos de las mismas.
EP4620521A3 (en) Methods and compositions relating to chondrisomes from cultured cells
MX385845B (es) Usos y composiciones de la flagelina
BR112016028891A2 (pt) processos de trens de sementes e usos dos mesmos
MX2014013913A (es) Usos terapeuticos de proteinas del factor de crecimiento del fibroblasto 21.
MX390739B (es) Composicion de hueso comprimido y metodo para usar la misma.
MX2018002318A (es) Proceso mejorado para producir fucoxantina y/o polisacaridos de microalgas.
CO2019012475A2 (es) Composiciones y productos de fragancia novedosos con efectos mejoradores del estado de ánimo
MY193650A (en) Extracellular matrix compositions
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
SV2017005585A (es) Peptidos lipidados resistentes a proteasas
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
MX2019008460A (es) Metodos para tratar esclerosis multiple usando celulas t autologas.
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
MX383460B (es) Derivados peptidicos novedosos y sus usos.
MX2016012314A (es) Analagos de apelina ciclicos.
UY35600A (es) "composiciones farmacéuticas que comprenden compuestos derivados de triazolopiridina y métodos para prepararlas"
GT201700139A (es) Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcina
BR112018074923A2 (pt) composição cosmética antissinais, uso da composição e método para tratamento antissinais
EA201692360A1 (ru) Косметическая композиция на основе митохондриально-адресованных антиоксидантов
UY35730A (es) Composiciones farmacéuticas comprendiendo kisspeptin o sus derivados